| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/03/2005 | CN1648134A Dog intravenous injection albumin, its preparing method and dog intravenous injection albumin preparation |
| 08/03/2005 | CN1213146C Process for producing recombinant insulin from novel fused protein |
| 08/03/2005 | CN1213141C Heterotrophic medium composition for transgenenic chlorella |
| 08/03/2005 | CN1213069C Growth promoting factor and its prepn and use |
| 08/03/2005 | CN1213068C Improvments in or relating to immune responses to HIV |
| 08/02/2005 | US6925394 Crystal structure of the 30s ribosome |
| 08/02/2005 | US6924414 Muir-torre-like syndrome in Fhit deficient mice |
| 08/02/2005 | US6924412 transgenic, non-human animal with a genome a that has stably integrated, recombinant nucleic acid encoding a polymeric immunoglobulin receptor protein linked to a mammary specific promoter |
| 08/02/2005 | US6924367 Method of modulating tissue growth using Frzb Protein |
| 08/02/2005 | US6924365 Optimized messenger RNA |
| 08/02/2005 | US6924364 Human secreted protein, Zzp1 |
| 08/02/2005 | US6924363 use in the separation and recovery of recombinant polypeptides from the cell due to the difference in densities between oil bodies and aqueous solutions |
| 08/02/2005 | US6924358 Protein for use in the treatment and diagnosis of cancer |
| 08/02/2005 | US6924357 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
| 08/02/2005 | US6924356 Human protein HHEPU32 |
| 08/02/2005 | US6924355 PRO1343 polypeptides |
| 08/02/2005 | US6924353 Inhibitors for RNA viruses |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6924265 Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases |
| 08/02/2005 | US6924264 chain extension of polypeptides using polymers selected from polyethylene glycol, polylactams, albumin, gelatin, acrylic polymers, fatty acids, polysaccharides, lipid and/or dextrans; antidiabetic agents |
| 08/02/2005 | US6924151 Binding particles; for use in the treatment of blood disorders |
| 08/02/2005 | US6924144 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 08/02/2005 | US6924142 Multipotent neural stem cells are proliferated in the presence of growth factors and erythropoietin which induces the generation of neuronal progenitor cells |
| 08/02/2005 | US6924132 Protein complementing yeast low temperature-sensitivity fermentability |
| 08/02/2005 | US6924128 Packaging cell lines for generation of high titers of recombinant AAV vectors |
| 08/02/2005 | US6924126 Cloning, expression and characterization of the SPG4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 08/02/2005 | US6924122 Protease regulator screening assay |
| 08/02/2005 | US6924121 Sperm specific proteins |
| 08/02/2005 | US6924120 sequence linked to a target protein, preferably an insulin precursor; present invention also relates to a process for obtaining a correctly folded insulin-precursor |
| 08/02/2005 | US6924119 cGMP-visualizing probe and a method of detecting and quantifying of cGMP by using the same |
| 08/02/2005 | US6924118 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 08/02/2005 | US6924117 Human RRP sequences and methods of use |
| 08/02/2005 | US6924110 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 08/02/2005 | US6924100 Nucleotide sequences coding preferential polypeptide for use in the treatment and diagnosis of cardiovascular disorders and headaches |
| 08/02/2005 | US6924095 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 08/02/2005 | US6923973 such as coccidioidomycosis and Valley Fever |
| 08/02/2005 | US6923972 Methods for use of genetically modified tumor-targeted bacteria with reduced virulence |
| 08/02/2005 | US6923970 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 08/02/2005 | US6923969 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
| 08/02/2005 | US6923964 amyloid fibrils; for preventing/treating amyloid diseases/Alzheimer's disease |
| 08/02/2005 | US6923963 Diagnosis of ehrlichia canis and ehrlichia chaffeensis |
| 08/02/2005 | US6923962 Peptide or antibody that competitively inhibits binding of CSP (competence signal peptide) to Streptococcus mutans histidine kinase; endocarditis |
| 08/02/2005 | US6923958 For immunizing a mammal against cancer cells that present a carcinoembryonic antigen (CEA) |
| 08/02/2005 | US6923957 Inactivated virulence genes |
| 08/02/2005 | US6923951 Non-invasive localization of a light-emitting conjugate in a mammal |
| 08/02/2005 | CA2341081C Cloning and expression of microbial phytase |
| 08/02/2005 | CA2175670C Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods |
| 08/02/2005 | CA2168617C Constitutive promoter from tobacco |
| 08/02/2005 | CA2148934C Targetable vector particles |
| 08/02/2005 | CA2118121C Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 08/02/2005 | CA2078539C Process for producing humanized chimera antibody |
| 07/30/2005 | CA2456593A1 Peptides for the diagnosis, monitoring and treatment of diabetes |
| 07/28/2005 | WO2005069187A2 Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation |
| 07/28/2005 | WO2005069011A1 Methods and means of screening for rhomboid activity |
| 07/28/2005 | WO2005069010A1 Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 4 (mglur4) |
| 07/28/2005 | WO2005069009A2 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN STEROID PROGESTIN RECEPTOR BETA (mSR-BETA) |
| 07/28/2005 | WO2005068999A1 Diagnostics and therapeutics for diseases associated with human progestin receptor gamma (mpr-gamma) |
| 07/28/2005 | WO2005068998A1 Diagnostics and therapeutics for diseases associated with human progestin receptor aplha (msr-alpha) |
| 07/28/2005 | WO2005068653A1 Method for detecting the risk of cardiovascular diseases such as acute myocardial infarction and coronary heart disease by analysing defensin |
| 07/28/2005 | WO2005068645A2 Anticariogenic proteins & peptides & saccharides |
| 07/28/2005 | WO2005068641A1 Integrase fusion proteins and their use with integrating gene therapy |
| 07/28/2005 | WO2005068640A2 Modified ksa and uses thereof |
| 07/28/2005 | WO2005068638A2 Promoter |
| 07/28/2005 | WO2005068635A2 Test system for the identification of antifungal agents |
| 07/28/2005 | WO2005068634A1 Hiv-1 indian subtype c vaccine constructs for use in humans |
| 07/28/2005 | WO2005068633A1 Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient |
| 07/28/2005 | WO2005068632A1 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRICTED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME |
| 07/28/2005 | WO2005068623A1 Method of screening remedy for rheumatoid arthritis |
| 07/28/2005 | WO2005068620A1 Method for the production of recombinant proteins |
| 07/28/2005 | WO2005068505A1 Fusion protein comprising tatdmt polypeptide |
| 07/28/2005 | WO2005068502A1 Method of lactoferrin separation and purification |
| 07/28/2005 | WO2005068501A1 Methods and compositions for modulating a steroid receptor |
| 07/28/2005 | WO2005068500A1 Process for the purification of bacterially expressed proteins |
| 07/28/2005 | WO2005068499A1 Compositions and methods for the high efficiency expression of the transforming growth factor-beta supergene family |
| 07/28/2005 | WO2005068498A2 Human therapeutic cells secreting nerve growth factor |
| 07/28/2005 | WO2005068497A1 Iis: a novel ifn-gamma-inducible protein, member of the secretoglobin family, that modulates cellular invasion and migration |
| 07/28/2005 | WO2005068496A1 Modulating viral transcription |
| 07/28/2005 | WO2005068495A1 Silk thread containing spider thread protein and silkworm producing the silk thread |
| 07/28/2005 | WO2005068494A2 Chimera botulinum toxin type e |
| 07/28/2005 | WO2005068493A1 Anthrax vaccine in the form of a spore |
| 07/28/2005 | WO2005068491A1 Antitumoral and antiviral peptides |
| 07/28/2005 | WO2005068489A1 Process for producing human serum albumin by heating in presence of divalent cation |
| 07/28/2005 | WO2005067981A1 Gene therapy for tumor using minus-strand rna virus vector encoding immunostimulating cytokine |
| 07/28/2005 | WO2005067968A1 Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses |
| 07/28/2005 | WO2005067965A2 Use of protein products for preventing and treating pancreatic diseases and/or obestiy and/or metabolic syndrome |
| 07/28/2005 | WO2005067960A1 HIV gp41 HR2-DERIVED SYNTHETIC PEPTIDES, AND THEIR USE IN THERAPY TO INHIBIT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS |
| 07/28/2005 | WO2005067958A2 Methods and compositions for the inhibition of cathepsins |
| 07/28/2005 | WO2005067957A2 Use of a dg147 protein product for preventing and treating metabolic disorders |
| 07/28/2005 | WO2005067709A2 Chimeric murine model comprising human hepatocytes user for screening compounds |
| 07/28/2005 | WO2005067543A2 Murine calicivirus |
| 07/28/2005 | WO2005067491A2 Toxin complex proteins and genes from xenorhabdus bovienii |
| 07/28/2005 | WO2005067478A2 Recombinant icosahedral virus like particle production in pseudomonads |
| 07/28/2005 | WO2005067368A2 Production of glucagon like peptide 2 and analogs |
| 07/28/2005 | WO2005052171A3 Retroviral and lentiviral vectors |
| 07/28/2005 | WO2005051988A3 Compositions and methods for the treatment of systemic lupus erythematosis |
| 07/28/2005 | WO2005051983A3 Oligomeric complexe formation of recombinant multi subunit chimeric polypeptides |
| 07/28/2005 | WO2005044839A3 Stabilized alpha helical peptides and uses thereof |
| 07/28/2005 | WO2005040212A3 Orthogonal gene switches |
| 07/28/2005 | WO2005037867B1 ALTERATION OF Fc-FUSION PROTEIN SERUM HALF-LIVES BY MUTAGENESIS OF POSITIONS 250, 314 AND/OR 428 OF THE HEAVY CHAIN CONSTANT REGION OF IG |
| 07/28/2005 | WO2005035557A3 Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease |